Table 2.
Radiation doses in recent CTO registries and meta-analyses.
| Study type | Characteristics | Year | CTO lesions (n) | Radiation skin injury (%) | Fluoroscopy time | |
|---|---|---|---|---|---|---|
| Lin et al. [32] | Retrospective study | 2014 | 516 | NR | 43 ± 27 # 42 ± 24 ## | |
| El Sabbagh et al. [7] | Metanalysis | Retrograde only | 2014 | 3493 | 0.5% | 82 ± 34 |
| Christopoulos et al. [33] | Registry | 2014 | 496 | NR | 41 (26-65) * | |
| Michael et al. [34] | Registry | 2013 | 1361 | NR | 42 ± 29 | |
| Karmpaliotis et al. [35] | Registry | Retrograde only | 2012 | 462 | NR | 61 ± 40 |
| Tsuchikane et al. [36] | Registry | Retrograde only | 2013 | 801 | NR | 95 ± 52 |
| Patel et al. [37] | Metanalysis | 2013 | 18941 | <0.01 | NR | |
| Galassi et al. [38] | Registry | 2011 | 1983 | NR | 42 ± 47 | |
| Morino et al. [8] | Registry | 2010 | 528 | 0 | 45 (1-301) * | |
| Aguiar-Souto et al. [39] | Retrospective study | 2010 | 227 | NR | 32 (19-47) * |
#CI-AKI group, ## non CI-AKI group, CI-AKI: contrast induced acute kidney injury, * Median (range)